Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)

Inclusion Criteria: * Adult male or female over 20 years of age. * Clinical diagnosis of advanced SMD. * The visual acuity of the eye to receive the transplant will be no better than hand movement. * The visual acuity of the eye that is not to receive the transplant will be no better than 24 (20/320) Early Treatment of Diabetic Retinopathy Study (ETDRS) letters. Exclusion Criteria: * History of malignancy. * History of myocardial infarction in previous 12 months. * History of diabetes mellitus. * Any immunodeficiency. * Any current immunosuppressive therapy other than intermittent or low dose cortico steroids. * Serologic evidence of infection with Hepatitis B, Hepatitis C, or HIV. * Current participation in any other clinical trial. * Participation within previous 6 months in any clinical trial of a drug by ocular or systemic administration. * Any other sight-threatening ocular disease. * Any chronic ocular medications. Any history of retinal vascular disease (compromised blood-retinal barrier). Glaucoma. Uveitis or other intraocular inflammatory disease. Significant lens opacities or other media opacity. Ocular lens removal within previous 3 months